GO
Loading...

Amgen Inc

More

  • Final Glance: Biotechnology companies Friday, 23 Jan 2015 | 6:04 PM ET

    Amgen Inc. rose$. 24 or. 2 percent, to $159.81. Biogen Idec rose $3.88 or 1.1 percent, to $357.53. Celgene Corp. rose$. 18 or. 1 percent, to $123.89.

  • Midday Glance: Biotechnology companies Friday, 23 Jan 2015 | 1:31 PM ET

    Amgen Inc. fell$. 45 or. 3 percent, to $159.12. Biogen Idec rose $4.60 or 1.3 percent, to $358.25. Celgene Corp. rose$. 04 or percent, to $123.75.

  • Early Glance: Biotechnology companies Friday, 23 Jan 2015 | 11:24 AM ET

    Amgen Inc. fell$. 51 or. 3 percent, to $159.07. Biogen Idec rose $2.25 or. 6 percent, to $355.90. Celgene Corp. fell$. 73 or. 6 percent, to $122.98.

  • Final Glance: Biotechnology companies Thursday, 22 Jan 2015 | 6:05 PM ET

    Amgen Inc. rose $2.19 or 1.4 percent, to $159.57. Biogen Idec fell $8.18 or 2.3 percent, to $353.65. Celgene Corp. rose $1.49 or 1.2 percent, to $123.71.

  • Midday Glance: Biotechnology companies Thursday, 22 Jan 2015 | 1:29 PM ET

    Amgen Inc. rose$. 42 or. 3 percent, to $157.80. Biogen Idec fell $10.37 or 2.9 percent, to $351.46. Celgene Corp. fell$. 20 or. 2 percent, to $122.02.

  • Early Glance: Biotechnology companies Thursday, 22 Jan 2015 | 12:09 PM ET

    Amgen Inc. fell $2.08 or 1.3 percent, to $155.30. Biogen Idec fell $10.44 or 2.9 percent, to $351.39. Celgene Corp. fell $1.14 or. 9 percent, to $121.08.

  • Final Glance: Biotechnology companies Wednesday, 21 Jan 2015 | 6:01 PM ET

    Amgen Inc. fell$. 22 or. 1 percent, to $157.38. Biogen Idec fell $1.46 or. 4 percent, to $361.83. Celgene Corp. fell $1.03 or. 8 percent, to $122.22.

  • Jan 21- The U.S. Food and Drug Administration approved Novartis AG's injectable drug, Cosentyx, to treat adults with a moderate to severe skin disease called plaque psoriasis. Eli Lilly and Co will begin marketing its IL-17 inhibitor ixekizumab in the first half of 2015, while Amgen Inc and AstraZeneca Plc's brodalumab reported positive results from a...

  • Midday Glance: Biotechnology companies Wednesday, 21 Jan 2015 | 1:22 PM ET

    Amgen Inc. rose$. 05 or percent, to $157.65. Biogen Idec rose$. 13 or percent, to $363.41. Celgene Corp. fell$. 83 or. 7 percent, to $122.42.

  • Early Glance: Biotechnology companies Wednesday, 21 Jan 2015 | 10:45 AM ET

    Amgen Inc. fell$. 68 or. 4 percent, to $156.93. Biogen Idec fell $2.04 or. 6 percent, to $361.24. Celgene Corp. fell$. 82 or. 7 percent, to $122.43.

  • Final Glance: Biotechnology companies Tuesday, 20 Jan 2015 | 6:35 PM ET

    Amgen Inc. fell$. 83 or. 5 percent, to $157.60. Biogen Idec rose $10.53 or 3.0 percent, to $363.28. Celgene Corp. rose $1.44 or 1.2 percent, to $123.25.

  • Midday Glance: Biotechnology companies Tuesday, 20 Jan 2015 | 1:33 PM ET

    Amgen Inc. fell $2.21 or 1.4 percent, to $156.22. Biogen Idec rose $3.65 or 1.0 percent, to $356.40. Celgene Corp. fell$. 30 or. 2 percent, to $121.51.

  • Early Glance: Biotechnology companies Tuesday, 20 Jan 2015 | 10:33 AM ET

    Amgen Inc. fell $2.17 or 1.4 percent, to $156.26. Biogen Idec fell $1.29 or. 4 percent, to $351.46. Celgene Corp. fell$. 73 or. 6 percent, to $121.08.

  • Midday Glance: Biotechnology companies Friday, 16 Jan 2015 | 1:18 PM ET

    Amgen Inc. rose $4.31 or 2.8 percent, to $156.23. Biogen Idec rose $6.94 or 2.0 percent, to $346.82. Celgene Corp. rose $2.15 or 1.8 percent, to $120.42.

  • Early Glance: Biotechnology companies Friday, 16 Jan 2015 | 10:13 AM ET

    Amgen Inc. rose $1.19 or. 8 percent, to $153.11. Biogen Idec rose $2.82 or. 8 percent, to $342.70. Celgene Corp. rose $1.77 or 1.5 percent, to $120.04.

  • Final Glance: Biotechnology companies Thursday, 15 Jan 2015 | 6:08 PM ET

    Amgen Inc. fell $3.24 or 2.1 percent, to $151.92. Biogen Idec fell $8.87 or 2.5 percent, to $339.88. Celgene Corp. fell $2.83 or 2.3 percent, to $118.27.

  • Midday Glance: Biotechnology companies Thursday, 15 Jan 2015 | 1:59 PM ET

    Amgen Inc. fell $2.75 or 1.8 percent, to $152.41. Biogen Idec fell $4.64 or 1.3 percent, to $344.11. Celgene Corp. fell $3.28 or 2.7 percent, to $117.82.

  • Early Glance: Biotechnology companies Thursday, 15 Jan 2015 | 11:00 AM ET

    Amgen Inc. fell $1.45 or. 9 percent, to $153.71. Biogen Idec fell $4.30 or 1.2 percent, to $344.45. Celgene Corp. fell $1.82 or 1.5 percent, to $119.28.

  • SAN FRANCISCO, Jan 15- The world's biggest drugmakers face a new reality when it comes to U.S. pricing for their products as insurers use aggressive tactics to extract steep price discounts, even for the newest medications. Big Pharma executives acknowledged the depth of change this week during public presentations and interviews with Reuters at the J.P....

  • Final Glance: Biotechnology companies Wednesday, 14 Jan 2015 | 6:07 PM ET

    Amgen Inc. rose$. 02 or percent, to $155.16. Biogen Idec fell $3.99 or 1.1 percent, to $348.75. Celgene Corp. rose $1.12 or. 9 percent, to $121.10.